Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725535 | SCV000337587 | pathogenic | not provided | 2015-11-13 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000365092 | SCV000793865 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2017-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000365092 | SCV001587216 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2023-02-24 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 284807). This premature translational stop signal has been observed in individual(s) with autosomal recessive limb-girdle muscular dystrophy (PMID: 9150160). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs776059672, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Phe239Leufs*14) in the CAPN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361). For these reasons, this variant has been classified as Pathogenic. |
Kariminejad - |
RCV001814147 | SCV001755644 | pathogenic | Abnormality of the musculature | 2021-07-10 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV000365092 | SCV002581072 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2022-08-01 | criteria provided, single submitter | clinical testing |